On Invalid Date, Senti Biosciences (NASDAQ: SNTI) reported Q4 2023 earnings per share (EPS) of -$0.42, up 75% year over year. Total Senti Biosciences earnings for the quarter were -$18.72 million. In the same quarter last year, Senti Biosciences's earnings per share (EPS) was -$0.24.
As of Q2 2024, Senti Biosciences's earnings has grown year over year. Senti Biosciences's earnings in the past year totalled -$71.06 million.
What is SNTI's earnings date?
Senti Biosciences's earnings date is Invalid Date. Add SNTI to your watchlist to be reminded of SNTI's next earnings announcement.
What was SNTI's revenue last quarter?
On Invalid Date, Senti Biosciences (NASDAQ: SNTI) reported Q4 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Senti Biosciences's revenue was $59.00 thousand.
What was SNTI's revenue growth in the past year?
As of Q2 2024, Senti Biosciences's revenue has grown -40.25% year over year. This is 184.88 percentage points lower than the US Biotechnology industry revenue growth rate of 144.63%. Senti Biosciences's revenue in the past year totalled $2.56 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.